The Hydrus Microstent is a revolutionary new therapy used during cataract surgery to help manage your glaucoma. It has been proven in global clinical trials to lower eye pressure, which resulted in a reduction of glaucoma medicine and, in some patients,eliminated the need for medication.
▪ 77% of Hydrus Microstent patients saw a significant reduction in eye pressure compared to cataract surgery alone.
▪78% of all Hydrus Microstent patients were drop free at 2 years compared to cataract surgery alone.
Roughly the size of an eyelash, the highly flexible Hydrus Microstent is placed by a surgeon during cataract surgery using microscopic incisions. This less invasive approach allows for fewer complications and faster healing times than traditional glaucoma surgery.
Hydrus Microstent reduces eye pressure in 3 ways:
▪ Enhancing aqueous outflow: Hydrus Microstent is placed in Schlemm’s canal, a part of the drainage system of the eye. Fluid then flows through the Hydrus Microstent and into the eye’s natural outflow channel to reduce eye pressure.
▪ Expanding the eye’s natural fluid pathway: Hydrus Microstent delicately expands Schlemm’s canal, allowing for enhanced flow through the eye’s drainage system.
▪ Reducing eye pressure: Hydrus Microstent spans a full 90 ̊ within the eye. This coverage ensures that fluid reaches the eye’s drainage system, which carries fluid from Schlemm’s canal to the body’s circulatory system and allows pressure in the eye to be lowered.